Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Treponema pallidum | polypeptide deformylase (def) | 0.0271 | 0.5 | 0.5 |
Mycobacterium leprae | PROBABLE POLYPEPTIDE DEFORMYLASE DEF (PDF) (FORMYLMETHIONINE DEFORMYLASE) | 0.0271 | 0.5 | 0.5 |
Mycobacterium ulcerans | peptide deformylase | 0.0271 | 0.5 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | peptide deformylase | 0.0271 | 0.5 | 0.5 |
Plasmodium falciparum | peptide deformylase | 0.0271 | 0.5 | 0.5 |
Mycobacterium tuberculosis | Probable polypeptide deformylase Def (PDF) (formylmethionine deformylase) | 0.0271 | 0.5 | 0.5 |
Plasmodium vivax | peptide deformylase, putative | 0.0271 | 0.5 | 0.5 |
Toxoplasma gondii | hypothetical protein | 0.0271 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Concentration (functional) | = 2 uM | Concentration required for half-maximal activation of LuxR protein was determined by following the luminescence of the biosensor strain | ChEMBL. | 11934577 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.